Congenital Hepatoblastoma in Alpacas: Liver Cancer in Crias

Congenital hepatoblastoma is a rare malignant tumor of immature liver cells that is present at birth or develops before a cria is born. In large animals, liver tumors are uncommon overall, and Merck notes that hepatoblastoma is one of the rare hepatic tumors reported in foals, young horses, and alpaca crias. A published veterinary case report also describes a neonatal alpaca cria with congenital hepatoblastoma, highlighting how unusual this diagnosis is.

This cancer starts in the liver, but the effects can reach far beyond that organ. The liver helps regulate blood sugar, protein production, bile flow, and toxin processing. When a tumor disrupts those jobs, a cria may become weak, fail to thrive, develop abdominal enlargement, or show signs of liver failure. Some crias may have only mild or vague abnormalities early on, which can make the condition hard to recognize without testing.

For pet parents, the hardest part is that this disease is both serious and uncommon. That means your vet may need to rule out more common causes of illness in crias first, such as infection, congenital defects, nutritional problems, or other liver disorders. A confirmed diagnosis usually requires imaging plus tissue evaluation.

The exact cause of congenital hepatoblastoma in alpacas is not well defined. In general, hepatoblastoma is thought to arise from primitive or embryonic liver cells that grow abnormally during fetal development. In the published neonatal alpaca case, the diagnosis was based on the tumor's microscopic appearance, including embryonal and fetal patterns, which supports a developmental origin rather than a tumor acquired later in life.

Because this disease is so rare in camelids, there is no proven prevention plan and no clearly established link to routine management choices, feed, or housing. That said, your vet may still consider whether other congenital abnormalities are present, because some birth defects can occur together even when they are not directly related.

It is also important to remember that not every liver mass in a cria is hepatoblastoma. Abscesses, cysts, hematomas, congenital malformations, and other tumors can look similar at first. That is why tissue diagnosis matters when possible.

Diagnosis starts with a full physical exam and a careful history, including age at onset, nursing behavior, growth, and any abdominal enlargement. Your vet will usually recommend bloodwork to look for anemia, inflammation, low blood sugar, protein changes, bilirubin changes, and liver-associated enzyme abnormalities. In large animals with hepatic tumors, Merck notes that liver enzymes may be increased, and alpha-fetoprotein can be elevated in hepatoblastoma or hepatocellular carcinoma.

Abdominal ultrasound is often the next step because it can help identify liver enlargement, a focal mass, fluid in the abdomen, or changes in liver texture. Cornell's camelid liver testing resources also support a liver-focused workup using chemistry testing such as GGT and related markers. Imaging helps your vet decide whether the liver is the likely source of illness and whether a biopsy is realistic.

A liver biopsy with histopathology is the usual way to confirm the diagnosis in a living animal, although this may not always be safe or practical in a fragile cria. Merck states that the presence and character of hepatic neoplasia can be confirmed by liver biopsy and microscopic examination. In some cases, the diagnosis is only made at necropsy, especially when signs were vague or the cria declined quickly.

There is no known guaranteed way to prevent congenital hepatoblastoma in alpacas. Because this tumor appears to arise during fetal development and is extremely rare, prevention is not like preventing an infectious disease or a parasite problem. Pet parents should be cautious about any source that promises a specific supplement, feed change, or management step will stop this cancer.

What you can do is focus on early detection and herd-level decision making. Careful newborn monitoring, daily nursing checks, weight tracking, and prompt evaluation of weak or poorly growing crias can help your vet identify serious liver disease sooner. Early workups also help rule out more common and sometimes treatable problems.

If a cria is confirmed or strongly suspected to have a congenital tumor, talk with your vet about whether a necropsy and review of the breeding history would be useful. That will not prevent the current case, but it may help your veterinary team and breeding program make more informed decisions in the future.